Osteopenia and osteoporosis in people living with HIV: multiprofessional approach

References

• LimaALZumiottiAVCamanhoGLOsteoarticular complications related to HIV infection and highly active anti-retroviral therapyBraz J Infect Dis200711442642917873999
   PubMed Web of Science ®Google Scholar
• AmorosaVTebasPBone disease and HIV InfectionClin Infect Dis200642110811416323100
   PubMed Web of Science ®Google Scholar
• BrueraDLunaNDavidDOBergoglioLMZamudioJDecreased bone mineral density in HIV-infected patients is independent of antiretroviral therapyAIDS200317131917192312960824
   PubMed Web of Science ®Google Scholar
• DelaunayCLoiseau-PeresSBenhamouCLOsteopenia and human immunodeficiency virusJoint Bone Spine200269210510812027299
   PubMed Web of Science ®Google Scholar
• DolanSEHuangJSKillileaKMSullivanMPAliabadiNGrinspoonSReduced bone density in HIV-infected womenAIDS200418347548315090800
   PubMed Web of Science ®Google Scholar
• JainRGLenhardJMSelect HIV protease inhibitors alter bone and fat metabolism ex vivoJ Biol Chem200227722192471925011937496
   PubMed Web of Science ®Google Scholar
• MoraSSalaNBricalliDZuinGChiumelloGViganòABone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapyAIDS200115141823182911579244
   PubMed Web of Science ®Google Scholar
• MoraSZamproniIBeccioSBianchiRGiacometVViganòALongitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected childrenJ Clin Endocrinol Metab2004891242814715822
   PubMed Web of Science ®Google Scholar
• TanBMNelsonRPJrJames-YarishMEmmnuealPSchurmanSJBone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitorJ Pediatr2001139344745111562628
   PubMed Web of Science ®Google Scholar
• GrijsenMLVrouenraetsSMSteingroverRHigh prevalence of reduced bone mineral density in primary HIV-1-infected menAIDS201024142233223820616695
   PubMed Web of Science ®Google Scholar
• SharmaAFlomPLWeedonJKleinRSProspective study of bone mineral density changes in aging men with or at risk for HIV infectionAIDS201024152337234520683316
   PubMed Web of Science ®Google Scholar
• McComseyGATebasPShaneEBone disease in HIV infection: a practical review and recommendations for HIV care providersClin Infect Dis201051893794620839968
   PubMed Web of Science ®Google Scholar
• MondyKTebasPEmerging bone problems in patients infected with human immunodeficiency virusClin Infect Dis200336Suppl 2S101S10512652379
   PubMed Web of Science ®Google Scholar
• SzejnfeldVLEpidemiologia da osteoporose e fraturasSzejnfeldVOsteoporose: Diagnóstico e TratamentoSãoPauloSarvier20006374
   Google Scholar
• BollandMJGreyABGambleGDReidIRLow body weight mediates the relationship between HIV infection and low bone mineral density: a metaanalysisJ Clin Endocrinol Metab200792124522452817925333
   PubMed Web of Science ®Google Scholar
• KopickoJJMomoduIAdedokumAHoffmanMClarkRAKissingerPCharacteristics of HIV-infected men with low serum testosterone levelsInt J STD AIDS1999101281782010639065
   PubMed Web of Science ®Google Scholar
• CarrAMillerJEismanJACooperDOsteopenia in HIV infected men: association with asyntomatic lactic academia and lower weight pre antiretroviral therapyAIDS200115670370911371684
   PubMed Web of Science ®Google Scholar
• AmielCOstertagASlamaLBMD is reduced in HIV-infected men irrespective of treatmentJ Bone Miner Res200419340240915040828
   PubMed Web of Science ®Google Scholar
• PakruddinJMLaurenceJHIV-1 Vpr enhances production of receptor of actived NF-KappaB ligant (RANKL) via potentiation of glucocorticoid receptor activityArch Virol20051501677815449141
   PubMed Web of Science ®Google Scholar
• HaugCJAukrustPHaugEMorkridLMullerFFrolandSSSevere deficiency of 1.25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasisJ Clin Endocrinol. Metab19988311383238389814454
   PubMed Web of Science ®Google Scholar
• BorderiMGibelliniDVesciniFMetabolic bone disease in HIV infectionAIDS200923111297131019550284
   PubMed Web of Science ®Google Scholar
• CastelHBonnehDYSherfMLielYAwareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fracturesOsteoporosis Int2001127559564
   Web of Science ®Google Scholar
• JenningsLAAuerbachADMaselliJPekowPSLindenauerPKLeeSJMissed opportunities for osteoporosis treatment in patients hospitalized for hip fractureJ Am Geriatr Soc201058465065720398147
   PubMed Web of Science ®Google Scholar
• Elliot-GibsonVBogochERJamalSABeatonDEPractice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic reviewOsteoporosis Int20041510767778
   PubMed Web of Science ®Google Scholar
• National Osteoporosis FoundationClinician’s Guide to Prevention and Treatment of OsteoporosisWashington, DCNational Osteoporosis Foundation2008 www.nof.org/physguideAccessed February 18, 2010
   Google Scholar
• TebasPPowderlyWGClaxtonSAccelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS2000144F63F6710770534
   PubMed Web of Science ®Google Scholar
• NegredoEGelEArisaERBone mineral density (BMD) in HIV-1-infected patientsProgram and Abstracts of the 8th Conference on Retroviruses and Opportunistic InfectionsChicago, Washington, DCFoundation for Retroviruses and Human Health2001232 [Abstract 626.]
   Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• National Academy of SciencesDietary Reference Intakes for Calcium and Vitamin D, 2011Washington DCThe National Academies Press2011 Available from: http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.aspAccessed June 9, 2011
   Google Scholar
• ChapuyMCPamphileRParisECombined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II studyOsteoporos Int200213325726411991447
   PubMed Web of Science ®Google Scholar
• HanleyDACranneyAJonesGVitamin D in adult health and disease: a review and guideline statement from Osteoporosis CanadaCMAJ201018212E610E61820624868
   PubMed Web of Science ®Google Scholar
• MolimardRPostecJPautasCBéguéACarbonnierJDelabeyeBDigestive absorption of calcium phosphates in manPresse Med19851445228322862935812
   PubMed Web of Science ®Google Scholar
• AutierPGandiniSVitamin D supplementation and total mortality: a meta-analysis of randomized controlled trialsArch Intern Med2007167161730173717846391
   PubMedGoogle Scholar
• PinheiroMMCastroMLCalcio e outros mineraisSzejnfeldVLOsteoporose: Diagnostico e TratamentoSãoPauloSarvier2000302320
   Google Scholar
• Institute of Medicine/Food and Nutrition BoardDietary reference intakes: applications in dietary assessmentWashingtonNational Academy Press2001306
   Google Scholar
• LinDRiederMJInterventions for the treatment of decreased bone mineral density associated with HIV infectionCochrane Database Syst Rev2007CD.005645
   Web of Science ®Google Scholar
• McComseyGAKendallMATebasPAlendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIVAIDS200721182473248218025884
   PubMed Web of Science ®Google Scholar
• RussellRGWattsNBEbetinoFHRogersMJMechanisms of action of biphosphonates: similarities and differences and their potential influence on clinical efficacyOsteoporosis Int2008196733759
   PubMed Web of Science ®Google Scholar
• BollandMJGreyABHorneAMBriggsSEThomasMGEllis-PeglerRBAnnual zoledronate increases bone density in highly active anti-retroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialJ Clin Endocrinol Metab20079241283128817227801
   PubMed Web of Science ®Google Scholar
• HuangJMeixnerLFernandezSMcCutchanJAA double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosisAIDS2009231515719050386
   PubMed Web of Science ®Google Scholar
• BorbaVZMañasNCThe use of PTH in the treatment of osteoporosisArq Bras Endocrinol Metabol201054221321920485911
   PubMedGoogle Scholar
• SainzMDel PozoJGAriasLHCarvajalAStrontium ranelate may cause alopeciaBMJ2009338b149419386675
   PubMed Web of Science ®Google Scholar
• McClungMRLewieckiEMCohenSBDenosumab in post-menopausal women with low bone mineral densityN Engl J Med2006354882183116495394
   PubMed Web of Science ®Google Scholar
• RietstchelPCorcoranCStanleyTBasgozNKlibanskiAGrinspoonSPrevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infections who were receiving hightly active antiretroviral therapyClin Infect Dis20003151240124411073758
   PubMed Web of Science ®Google Scholar
• AroraSAgrawalMSunLDuffooFZaidiMIqbalJHIV and bone lossCurr Osteoporos Rep20108421922620830538
   PubMedGoogle Scholar
• World Health OrganizationAIDS Epidemic Update: December 2003Geneva, SwitzerlandUNAIDS Available at: http://www.who.int/hiv/pub/epidemioloy/epi2003/enAccessed June 9, 2011
   Google Scholar
• SepkowitzKAIDS – the first 20 yearsN Engl J Med2001344231764177211396444
   PubMed Web of Science ®Google Scholar
• SansoneGRFrengleyJDImpact of HAART on causes of death of persons with late-stage AIDSJ Urban Health200077216617510855998
   PubMed Web of Science ®Google Scholar
• ArpadiSHorlickMThorntonJCuffPWangJQuezadaSDecreases in total body bone mineral content progress with age in HIV-infected childrenProgram Abstr 8th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 8th 2001Chic Ill2001 Feb 4–8;8:278 abstract no. LB8
   Google Scholar
• CarrAOsteopenia in HIV infectionNational AIDS Treatment advocacy project www.natap.org/2000/lipo/osteopenia011501.htm2000
   Google Scholar
• CarrACardiovascular risk factors in HIV-infected patientsJ Acquir Immune Defic Syndr200334Suppl 1S737814562861
   PubMed Web of Science ®Google Scholar
• ThompsonPDBuchnerDPinaILExercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)Circulation2003107243109311612821592
   PubMed Web of Science ®Google Scholar
• ScevolaDDi MatteoALanzariniPEffect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapyAIDS200317Suppl 1S123S12912870538
   PubMed Web of Science ®Google Scholar
• LittlePMargettsBThe importance of diet and physical activity in the treatment of conditions managed in general practiceBr J Gen Pract1996464041871928731628
   PubMed Web of Science ®Google Scholar
• JovineMSBuchallaCMSantarémÉMSantarémJMAldrighiJMEfeito do treinamento resistido sobre a osteoporose após a menopausa: estudo de atualização/Effect of resistance training on postmenopausal osteoporosis: updateRev Bras Epidemiol200694493505
   Google Scholar
• LiraniGRebucciAPLazarettiCMAbordagem física para pre-venção e tratamento de osteoporoseArq Bras Endocrinol Metabol201054217117820485906
   PubMedGoogle Scholar